drugset / Trial / NCT03184402

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)

NCT03184402

Phase 3 Completed 124 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.

Timeline

Start
2017-04-24
Primary completion
2017-07-31
Completion
2017-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject DWJ1252 Unknown
Comparator Mosapride Small molecule

Indications